Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual vs Oral Vitamin B12 for PPI-Associated Deficiency
NCT06966856Phase 3Not yet recruiting
- Sponsor
- Tanta University
- Start
- Dec 2026
- Primary completion
- Dec 2028
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 3, randomised, open-label trial of cyanocobalamin in vitamin B12 deficiency (3 arms), sponsored by Tanta University. Primary endpoint: Change in Serum Vitamin B12 Concentration at 6 weeks. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
cyanocobalamin
03
Conditions
vitamin B12 deficiency
Beyond the preview
Go deeper on NCT06966856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06966856.